A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Clinical trial NCT07668336 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07668336
- Sponsor
- Eli Lilly and Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2030-03-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.